Newsroom

START Dublin will offer patients with advanced cancer the opportunity to participate in cutting edge research and enhance the availability of new cancer drugs 14 October 2024 The Minister for Public Expenditure, NDP Delivery and Reform, Paschal Donohoe TD has today (Monday) officially opened START Dublin, the Republic of Ireland’s first dedicated Phase I Clinical […]

San Antonio, TX – October 8, 2024. The START Center for Cancer Research (“START”) proudly announces that Amita Patnaik, MD, FRCPC, has been named to the prestigious PharmaVoice 100 list as a “Cancer Care Visionary.” This annual award celebrates inspiring individuals in life sciences who are making a profound impact on the field and driving

Dr. Takimoto to propel scientific and medical strategies and advance START’s leadership in global early-phase cancer research San Antonio, TX – October 2, 2024. The START Center for Cancer Research (“START”) proudly announces the appointment of Chris H. Takimoto, MD, PhD, FACP, as its new Chief Medical Officer. Dr. Takimoto, a renowned physician-scientist, oncology drug

New Series Unites Global Experts to Explore the Future of Oncology Research in Community Settings San Antonio, TX – August 29, 2024. The START Center for Cancer Research (“START”), the largest global network of fully dedicated, community-based, early-phase oncology clinical trial sites, is proud to announce the launch of its Virtual Panel Series, titled “The

New START early-phase clinical trial site brings advanced cancer research to Northwell’s Cancer Institute New Hyde Park, NY / San Antonio, TX – May 31, 2024.  Northwell Health, New York State’s largest health care provider, and The START Center for Cancer Research (“START”), renowned for being the largest global network of fully dedicated, community-based, early-phase

The START Center for Cancer Research (“START”) is set to have a significant presence at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting. Known for our commitment to the advancement of cancer research and treatment, we are excited to share that our team of Principal Investigators (PIs) will be involved in nearly 100

New CEO Nick Slack selected to lead the organization in its next phase of growth SAN ANTONIO–(BUSINESS WIRE)–The START Center for Cancer Research, the world’s largest global site network of early phase oncology clinical trials, sets its sights on expanding access to breakthrough research to all communities globally. Currently running one of the largest portfolios

A Marathon and a Sprint The process of developing and bringing new medicines to patients in need is oftentimes lengthy and complex, which is why anything that can be done to expedite this process is critical for patients who are waiting for new treatment options. In the case of B6A, Seagen’s investigational antibody-drug conjugate (ADC),

2023 ASCO – Next Generation Immunotherapy Congratulations to Dr. Emiliano Calvo, Director of START Spain, for leading the discussion of Next Generation Immunotherapy agents on June 4th during the ASCO annual meeting. read Linked Post Here

2022 ESMO IMMUNO-ONCOLOGY (ESMO IO) ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and abstracts at this year’s ESMO IO meeting in Geneva, Switzerland. Congratulations to the START physician team, Dr. Kyriakos Papadopoulos, Dr. Nehal Lakhani, Dr. Manish Sharma, Dr. Amita Patnaik, Dr. Drew Rasco, and Dr. Victor Moreno, for their contributions